Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse

Neuroscience

Volumn 113, Issue 3, 2002, Pages 671-682

  Wallmichrath, I ^a   Szabo, B ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cannabinoid receptor; Catalepsy; Depolarization induced suppression of inhibition; Extrapyramidal motor system; IPSC; Patch clamp

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID RECEPTOR; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; MUSCIMOL; RIMONABANT; TETRODOTOXIN; 4 AMINOBUTYRIC ACID; CANNABINOID RECEPTOR; DOPAMINE; DRUG RECEPTOR; ENDOCANNABINOID;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CELL DENSITY; CONTROLLED STUDY; DEPOLARIZATION; ELECTROSTIMULATION; INHIBITORY POSTSYNAPTIC POTENTIAL; MOUSE; NERVE CONDUCTION; NERVE ENDING; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PATCH CLAMP; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOSTRIATUM; NERVE CELL INHIBITION; NERVE TRACT; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMAL; CANNABINOIDS; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; IMMUNOHISTOCHEMISTRY; MICE; NEOSTRIATUM; NEURAL INHIBITION; NEURAL PATHWAYS; PATCH-CLAMP TECHNIQUES; RECEPTORS, DRUG; SUBSTANTIA NIGRA; SUPPORT, NON-U.S. GOV'T; SYNAPTIC TRANSMISSION; ANIMALS; ENDOCANNABINOIDS; RECEPTORS, CANNABINOID;

EID: 0037008878     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00109-4     Document Type: Article

References (66)

1. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices
2. Synaptic organisation of the basal ganglia
3. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a Pertussis toxin-sensitive mechanism
4. Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist
5. Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium
6. Marihuana. Pharmacological aspects of drug dependence
7. Immunohistochemical localization of the neural cannabinoid receptor in rat brain
8. Substantia nigra
9. Cannabinoid receptors and their endogenous agonists
10. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors
11. Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor
12. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum
13. Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
14. A receptor alterations in the human basal ganglia in Huntington's disease
15. Loss of cannabinoid receptors in the substantia nigra in Huntington's disease
16. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
17. Nigral GABAergic mechanisms and EMG activity in rats: Differences between pars reticulata and pars compacta
18. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes
19. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
20. A synaptic transmission in the hippocampus
21. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: A comparison with opioids
22. 1 receptor mRNA in neuronal subpopulations of rat striatum: A double-label in situ hybridization study
23. Pharmacology of cannabinoid receptors
24. 1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons
25. Surround inhibition among projection neurons is weak or nonexistent in the rat neostriatum
26. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles
27. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons
28. The role of the ventromedial thalamic nucleus in the catalepsy evoked from the substantia nigra pars reticulata in rats
29. Aminoalkylindole binding in rat cerebellum: Selective displacement by natural and synthetic cannabinoids
30. 3H]GABA in the substantia nigra of the rat: Relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons
31. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells
32. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor
33. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
34. Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN 55,212-2
35. 9-tetrahydrocannabinol reduces γ-aminobutyric acid uptake in the globus pallidus
36. Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens
37. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain
38. Localization of cannabinoid receptor mRNA in rat brain
39. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a Xenopus oocyte expression system
40. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata
41. Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata
42. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals
43. Pharmacology of cannabinoid receptor ligands
44. Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids
45. A synaptic currents in the rat substantia nigra pars reticulata
46. Electrophysiological and immunocytochemical characterization of GABA and dopamine neurons in the substantia nigra of the rat
47. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
48. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens
49. Motor actions of cannabinoids in the basal ganglia output nuclei
50. B and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones
51. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands
52. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones
53. Patch-clamp recordings from the soma and dendrites of neurons in brain slices using infrared video microscopy
54. Mechanisms of presynaptic inhibition studied using paired-pulse facilitation
55. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in ratcorpus striatum
56. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata
57. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells
58. Presynaptic inhibition in the hippocampus
59. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat CNS
60. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
61. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro
62. Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro
63. Effects of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata
64. Presynaptic specificity of endocannabinoid signaling in the hippocampus
65. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
66. Presynaptic inhibition of elicited neurotransmitter release